SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-277807
Filing Date
2015-08-05
Accepted
2015-08-05 08:21:01
Documents
6
Period of Report
2015-08-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d35780d8k.htm 8-K 40860
2 EX-2.1 d35780dex21.htm EX-2.1 527788
3 EX-10.1 d35780dex101.htm EX-10.1 96644
4 EX-99.1 d35780dex991.htm EX-99.1 25225
5 GRAPHIC g35780g01p85.jpg GRAPHIC 7155
6 GRAPHIC g35780g86f65.jpg GRAPHIC 21218
  Complete submission text file 0001193125-15-277807.txt   725641
Mailing Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2
Business Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2 (216) 523-5000
Allergan plc (Filer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36867 | Film No.: 151027556
SIC: 2834 Pharmaceutical Preparations